NPNCX | RMFEX | NPNCX / RMFEX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 15 years | 23 years | - |
Gain YTD | 3.882 | 4.133 | 94% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.61B | 104B | 8% |
Annual Yield % from dividends | 1.31 | 1.95 | 67% |
Returns for 1 year | 15.84 | 14.14 | 112% |
Returns for 3 years | 8.92 | 18.40 | 49% |
Returns for 5 years | 51.12 | 43.83 | 117% |
Returns for 10 years | 43.82 | 72.73 | 60% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBIOX | 19.14 | 0.26 | +1.38% |
Fidelity Select Biotechnology | |||
VSMPX | 275.93 | 1.41 | +0.51% |
Vanguard Total Stock Mkt Idx Instl Pls | |||
BRWCX | 24.72 | 0.10 | +0.41% |
MFS Blended Research Growth Eq C | |||
LMCFX | 35.22 | 0.10 | +0.28% |
Lord Abbett Mid Cap Stock F | |||
QSERX | 17.70 | 0.05 | +0.28% |
AQR Small Cap Multi-Style R6 |